Facial Plast Surg 2016; 32(06): 656-661
DOI: 10.1055/s-0036-1596045
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Isotretinoin Use in Thick-Skinned Rhinoplasty Patients

Roxana Cobo
1   Division of Facial Plastic Surgery, Department of Otolaryngology, Centro Medico Imbanaco, Cali, Colombia
,
Liliana Vitery
2   Department of Otolaryngology, Rivas Clinic, Bogota, Colombia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
29. Dezember 2016 (online)

Abstract

One of the characteristics of mestizo patients can be the thick sebaceous skin associated with a poor osteocartilaginous underlying nasal structure. In spite of using a proper structural approach where grafts and sutures are used to define the nasal tip, frequently the results are suboptimal. Surgical techniques have been described to reduce the thickness of the skin-soft tissue envelope, but these frequently give unreliable results. The monitored use of isotretinoin given orally as a complement after performing a rhinoplasty can adequately control the production of the sebaceous glands and thin the skin-subcutaneous tissue envelope in a uniform fashion without compromising the underlying bony and cartilaginous structures of the nose. Patients ideally should be treated jointly with a dermatologist and be followed closely to monitor hepatic function. Follow-up after 2 years with pre- and postoperative pictures shows improved definition of the nasal tip and dramatic improvement on sebaceous gland production.

 
  • References

  • 1 Peck GC. Rhinoplasty: external shaving is invaluable in treating thick, sebaceous skin. Aesthet Surg J 1997; 17 (6) 414
  • 2 Thomas M, D'Silva J. Ethnic rhinoplasty. Oral Maxillofac Surg Clin North Am 2012; 24 (1) 131-148
  • 3 Cobo R. Rhinoplasty in the mestizo nose. Facial Plast Surg Clin North Am 2014; 22 (3) 395-415
  • 4 Cobo R. Hispanic/mestizo rhinoplasty. Facial Plast Surg Clin North Am 2010; 18 (1) 173-188
  • 5 Toriumi DM, Pero CD. Asian rhinoplasty. Clin Plast Surg 2010; 37 (2) 335-352
  • 6 Toriumi DM, Swartout B. Asian rhinoplasty. Facial Plast Surg Clin North Am 2007; 15 (3) 293-307 , v
  • 7 Nassif PS, Lee KJ. Asian rhinoplasty. Facial Plast Surg Clin North Am 2010; 18 (1) 153-171
  • 8 Patel AD, Kridel RW. African-American rhinoplasty. Facial Plast Surg 2010; 26 (2) 131-141
  • 9 Nemati S, Golchay J, Iranfar K, Alizadeh A. Frequency of acne vulgaris and its exacerbation in facial and periorbital area after septorhinoplasty. Am J Otolaryngol 2013; 34 (5) 378-381
  • 10 Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol 2002; 46 (4) 505-509
  • 11 Toriumi DM. New concepts in nasal tip contouring. Arch Facial Plast Surg 2006; 8 (3) 156-185
  • 12 Orozco B, Campo ME, Anaya LA , et al. Guías colombianas para el manejo del acné: una revisión basada en la evidencia por el Grupo Colombiano de Estudio en Acné. Rev Assoc Colomb Dermatol 2011; 19: 129-158
  • 13 Dréno B, Bettoli V, Ochsendorf F , et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 16 (5) 565-571
  • 14 Husein-ElAhmed H, Armijo-Lozano R. Management of severe rhinophyma with sculpting surgical decortication. Aesthetic Plast Surg 2013; 37 (3) 572-575
  • 15 Tagliolatto S, Santos Neto OdeO, Alchorne MM, Enokihara MY. Sebaceous hyperplasia: systemic treatment with isotretinoin. An Bras Dermatol 2015; 90 (2) 211-215
  • 16 Goldsmith LA, Bolognia JL, Callen JP , et al; American Academy of Dermatology. American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 2004; 50 (6) 900-906
  • 17 Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies. Clin Dermatol 2010; 28 (1) 24-30
  • 18 On SC, Zeichner J. Isotretinoin updates. Dermatol Ther (Heidelb) 2013; 26 (5) 377-389
  • 19 Thomas DR. Psychosocial effects of acne. J Cutan Med Surg 2004; 8 (Suppl. 04) 3-5
  • 20 Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett 2004; 9 (7) 1-3 , 9
  • 21 Rapp DA, Brenes GA, Feldman SR , et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004; 151 (1) 183-189
  • 22 Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009; 1 (3) 162-169
  • 23 Dalziel K, Barton S, Marks R. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol 1987; 117 (3) 317-323
  • 24 King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107 (5) 583-590
  • 25 Falcon RH, Lee WL, Shalita AR, Suntharalingam K, Fikrig SM. In vitro effect of isotretinoin on monocyte chemotaxis. J Invest Dermatol 1986; 86 (5) 550-552
  • 26 Zaenglein AL, Pathy AL, Schlosser BJ , et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74 (5) 945-73.e33
  • 27 Truchuelo MT, Jiménez N, Mavura D, Jaén P. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin. Actas Dermosifiliogr 2015; 106 (2) 126-132
  • 28 Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006; 142 (8) 1016-1022
  • 29 Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial. Indian J Dermatol Venereol Leprol 2011; 77 (6) 688-694
  • 30 Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 2007; 299 (10) 467-473
  • 31 Chandrashekar BS, Varsha DV, Vasanth V, Jagadish P, Madura C, Rajashekar ML. Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients. Int J Dermatol 2014; 53 (10) 1281-1285
  • 32 Kim HW, Chang SE, Kim JE, Ko JY, Ro YS. The safe delivery of fractional ablative carbon dioxide laser treatment for acne scars in Asian patients receiving oral isotretinoin. Dermatol Surg 2014; 40 (12) 1361-1366
  • 33 Yoon JH, Park EJ, Kwon IH , et al. Concomitant use of an infrared fractional laser with low-dose isotretinoin for the treatment of acne and acne scars. J Dermatolog Treat 2014; 25 (2) 142-146
  • 34 Cobo R. Rhinoplasty in Latino patients. Clin Plast Surg 2016; 43 (1) 237-254
  • 35 Muccini Jr JA. The dermatologist and the facial plastic surgeon. Facial Plast Surg Clin North Am 2003; 11 (2) 197-207
  • 36 Hafezi F, Naghibzadeh B, Nouhi A. Management of the thick-skinned nose: a more effective approach. Ann Otol Rhinol Laryngol 2006; 115 (6) 444-449
  • 37 Rohrich RJ, Ghavami A. Rhinoplasty for Middle Eastern noses. Plast Reconstr Surg 2009; 123 (4) 1343-1354
  • 38 Ortiz-Monasterio F, Lopez-Mas J, Araico J. Rhinoplasty in the thick-skinned nose. Br J Plast Surg 1974; 27 (1) 19-24
  • 39 Hanasono MM, Kridel RW, Pastorek NJ, Glasgold MJ, Koch RJ. Correction of the soft tissue pollybeak using triamcinolone injection. Arch Facial Plast Surg 2002; 4 (1) 26-30 , discussion 31
  • 40 Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol 2015; 172 (Suppl. 01) 27-36
  • 41 Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology 2003; 206 (1) 37-53